Docebo Inc. Cost Of Sales
Docebo Inc. (DCBO) reported Cost Of Sales of $47.85 million for the 12-month period ending 2025-12-31, per its 40-F filed 2026-02-27.
Financial Statements › Expense Statement
ifrs-full:CostOfSales · last filed 2026-02-27
- Docebo Inc. cost of sales for the quarter ending 2025-03-31 was $11.39M, a 14.80% increase year-over-year.
- Docebo Inc. cost of sales for the quarter ending 2024-12-31 was $10.65M, a 15.07% increase year-over-year.
- Docebo Inc. cost of sales for the quarter ending 2024-09-30 was $10.46M, a 19.17% increase year-over-year.
- Docebo Inc. cost of sales for the quarter ending 2024-03-31 was $9.93M, a 23.24% increase year-over-year.
| Period end | Cost Of Sales 3 month | Cost Of Sales 6 month | Cost Of Sales 9 month | Cost Of Sales 12 month |
|---|---|---|---|---|
| 2025-12-31 | $47.85M 40-F · filed 2026-02-27 | |||
| 2025-03-31 | $11.39M 6-K · filed 2025-05-09 | $22.05M derived: sum of 2 quarters · filed 2026-02-27 | $32.51M derived: sum of 3 quarters · filed 2026-02-27 | |
| 2024-12-31 | $10.65M derived: 40-F 12 month − 6-K 9 month · filed 2026-02-27 | $21.11M derived: sum of 2 quarters · filed 2026-02-27 | $41.30M 40-F · filed 2026-02-27 | |
| 2024-09-30 | $10.46M 6-K · filed 2024-11-08 | $30.64M 6-K · filed 2024-11-08 | ||
| 2024-03-31 | $9.93M 6-K · filed 2025-05-09 | $19.18M derived: sum of 2 quarters · filed 2025-05-09 | $27.96M derived: sum of 3 quarters · filed 2025-05-09 | $36.37M derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $9.26M derived: 40-F 12 month − 6-K 9 month · filed 2025-02-28 | $18.03M derived: sum of 2 quarters · filed 2025-02-28 | $26.44M derived: sum of 3 quarters · filed 2025-02-28 | $34.50M 40-F · filed 2025-02-28 |
| 2023-09-30 | $8.78M 6-K · filed 2024-11-08 | $17.19M derived: sum of 2 quarters · filed 2024-11-08 | $25.24M 6-K · filed 2024-11-08 | $32.75M derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $8.41M 6-K · filed 2023-08-10 | $16.46M 6-K · filed 2023-08-10 | $23.97M derived: sum of 3 quarters · filed 2024-05-10 | $31.11M derived: sum of 4 quarters · filed 2024-05-10 |
| 2023-03-31 | $8.05M 6-K · filed 2024-05-10 | $15.56M derived: sum of 2 quarters · filed 2024-05-10 | $22.70M derived: sum of 3 quarters · filed 2024-05-10 | $29.68M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $7.51M derived: 40-F 12 month − 6-K 9 month · filed 2024-02-23 | $14.65M derived: sum of 2 quarters · filed 2024-02-23 | $21.63M derived: sum of 3 quarters · filed 2024-02-23 | $28.18M 40-F · filed 2024-02-23 |
| 2022-09-30 | $7.14M 6-K · filed 2023-11-09 | $14.12M derived: sum of 2 quarters · filed 2023-11-09 | $20.67M 6-K · filed 2023-11-09 | $26.76M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $6.98M 6-K · filed 2023-08-10 | $13.53M 6-K · filed 2023-08-10 | $19.62M derived: sum of 3 quarters · filed 2023-08-10 | $25.30M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $6.55M 6-K · filed 2023-05-11 | $12.64M derived: sum of 2 quarters · filed 2023-05-11 | $18.32M derived: sum of 3 quarters · filed 2023-05-11 | $23.47M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $6.09M derived: 40-F 12 month − 6-K 9 month · filed 2023-03-09 | $11.77M derived: sum of 2 quarters · filed 2023-03-09 | $16.92M derived: sum of 3 quarters · filed 2023-03-09 | $20.79M 40-F · filed 2023-03-09 |
| 2021-09-30 | $5.68M 6-K · filed 2022-11-10 | $10.84M derived: sum of 2 quarters · filed 2022-11-10 | $14.70M 6-K · filed 2022-11-10 | |
| 2021-06-30 | $5.15M 6-K · filed 2022-08-11 | $9.02M 6-K · filed 2022-08-11 | ||
| 2021-03-31 | $3.86M 6-K · filed 2022-05-12 | |||
| 2020-12-31 | $11.54M 40-F · filed 2022-03-10 | |||
| 2019-12-31 | $8.37M 40-F · filed 2021-03-11 |